SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-055347
Filing Date
2021-11-09
Accepted
2021-11-08 18:08:33
Documents
59
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q acad-10q_20210930.htm   iXBRL 10-Q 2282903
2 EX-31.1 acad-ex311_8.htm EX-31.1 9491
3 EX-32.1 acad-ex321_6.htm EX-32.1 6350
  Complete submission text file 0001564590-21-055347.txt   7562614

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acad-20210930.xsd EX-101.SCH 41907
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acad-20210930_cal.xml EX-101.CAL 56260
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acad-20210930_def.xml EX-101.DEF 102560
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20210930_lab.xml EX-101.LAB 300195
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20210930_pre.xml EX-101.PRE 235228
9 EXTRACTED XBRL INSTANCE DOCUMENT acad-10q_20210930_htm.xml XML 1535094
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 211389213
SIC: 2834 Pharmaceutical Preparations